| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 3 | +100.00% | +14.19% | -0.43% | +14.62% | +20.01% | — |
| 14d | 3 | +66.67% | +17.75% | -0.60% | +18.35% | +27.74% | — |
| 30d | 3 | +66.67% | +10.08% | -1.69% | +11.77% | +19.58% | — |
| 60d | 3 | +66.67% | +14.60% | +3.62% | +10.98% | +24.38% | — |
| 90d | 3 | +66.67% | -1.64% | +8.77% | -10.41% | -4.14% | — |
| 180d | 3(3 pending) | — | — | — | — | — | — |
| 1y | 3(3 pending) | — | — | — | — | — | — |
| 2y | 3(3 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ONCY ONCOLYTICS BIOTECH INC | PURCHASEGRANT Stock grant | 755,000 | — | — | 755,000 | Jun 1, 2026 | Jun 3, 2026 ↗ | View → |
| ONCY ONCOLYTICS BIOTECH INC | PURCHASE Chief Executive Officer | 5,050 | $0.96 | $4.8K | 114,050 | Mar 12, 2026 | Mar 13, 2026 ↗ | View → |
| ONCY ONCOLYTICS BIOTECH INC | PURCHASE Chief Executive Officer | 29,500 | $0.84 | $24.8K | 109,000 | Feb 12, 2026 | Feb 13, 2026 ↗ | View → |
| ONCY ONCOLYTICS BIOTECH INC | PURCHASE Chief Executive Officer | 5,600 | $0.84 | $4.7K | 79,500 | Feb 11, 2026 | Feb 13, 2026 ↗ | View → |